$2.46
2.50%
Nasdaq, Sep 05, 10:13 pm CET
ISIN
US00091E1091
Symbol
ABSI

Absci Corp Stock price

$2.46
-0.49 16.61% 1M
-0.90 26.79% 6M
-0.16 6.11% YTD
-1.67 40.44% 1Y
-0.93 27.43% 3Y
-13.54 84.63% 5Y
-13.54 84.63% 10Y
-13.54 84.63% 20Y
Nasdaq, Closing price Fri, Sep 05 2025
+0.06 2.50%
ISIN
US00091E1091
Symbol
ABSI
Industry

Key metrics

Basic
Market capitalization
$367.8m
Enterprise Value
$252.5m
Net debt
positive
Cash
$117.5m
Shares outstanding
127.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
88.8 | 56.1
EV/Sales
61.0 | 38.5
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
83.9%
Return on Equity
-57.6%
ROCE
-66.5%
ROIC
-168.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$4.1m | $6.6m
EBITDA
$-106.0m | $-99.9m
EBIT
$-118.7m | $-121.0m
Net Income
$-113.3m | $-109.1m
Free Cash Flow
$-76.7m
Growth (TTM | estimate)
Revenue
27.4% | 44.8%
EBITDA
-25.5% | -6.1%
EBIT
-20.8% | -12.6%
Net Income
-22.8% | -5.9%
Free Cash Flow
-26.5%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,562.4% | -1,521.9%
EBIT
-2,868.3%
Net
-2,737.9% | -1,663.4%
Free Cash Flow
-1,854.2%
More
EPS
$-0.9
FCF per Share
$-0.6
Short interest
24.6%
Employees
157
Rev per Employee
$30.0k
Show more

Is Absci Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Absci Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Absci Corp forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Absci Corp forecast:

Buy
93%
Hold
7%

Financial data from Absci Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4.14 4.14
27% 27%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 36 36
2% 2%
871%
- Research and Development Expense 72 72
41% 41%
1,735%
-106 -106
26% 26%
-2,561%
- Depreciation and Amortization 13 13
8% 8%
306%
EBIT (Operating Income) EBIT -119 -119
21% 21%
-2,867%
Net Profit -113 -113
23% 23%
-2,737%

In millions USD.

Don't miss a Thing! We will send you all news about Absci Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Absci Corp Stock News

Neutral
GlobeNewsWire
13 days ago
World-renowned experts will guide the clinical development of ABS-201, a therapeutic antibody entering clinical trials for the treatment of androgenetic alopecia. World-renowned experts will guide the clinical development of ABS-201, a therapeutic antibody entering clinical trials for the treatment of androgenetic alopecia.
Neutral
GlobeNewsWire
19 days ago
VANCOUVER, Wash. and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences:
Neutral
Seeking Alpha
26 days ago
Absci Corporation (NASDAQ:ABSI ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Alexander Khan - VP of Finance & Head of Investor Relations Christian Stegmann - Senior Vice President of Drug Creation Sean McClain - Founder, CEO, President & Director Zachariah Jonasson - Chief Business Officer & CFO Conference Call Participants Alexander Xenakis - Unidentified C...
More Absci Corp News

Company Profile

AbSci Corp. engages in the development of protein biomanufacturing technology. It offers SoluPro, an all-in-one protein expression platform which produces complex proteins using simplest and least expensive organism. The company was founded by Sean Mcclain and Mark Valasek in 2011 and is headquartered in Vancouver, WA.

Head office United States
CEO Sean McClain
Employees 157
Founded 2011
Website www.absci.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today